Where You Live in Rural America Shapes When Your Breast Cancer Gets Found

American College of Surgeons

Rural America is not one place. It is hundreds of different places with different hospitals, different insurance landscapes, and vastly different odds of catching breast cancer before it spreads. A national study published in the Journal of the American College of Surgeons makes that variation visible for the first time, and the numbers are hard to look away from.

52,000 women, 17 years of data

Researchers at Washington University in St. Louis analyzed records from 52,287 rural women diagnosed with breast cancer between 2004 and 2021, drawn from the American College of Surgeons National Cancer Database. They defined "rural" as counties with no towns or cities, or where the largest town had fewer than 2,500 residents, and then sorted the data by U.S. Census region.

Overall, 13.6% of rural patients were diagnosed with advanced breast cancer (Stage 3 or 4), compared with 12% in non-rural areas. That gap is notable but not surprising. What the researchers found within rural communities was far more striking.

The southern penalty

Using the West North Central region (Iowa to the Dakotas) as a statistical reference, the study found that women in the East South Central region, which includes Alabama, Kentucky, Mississippi, and Tennessee, were about 34% more likely to be diagnosed with Stage 4 breast cancer. Women in the West South Central region (Arkansas, Louisiana, Oklahoma, Texas) faced a 33% increased risk of Stage 4 diagnosis.

These are not small differences. Stage 4 breast cancer has a five-year survival rate of roughly 33%, compared with 87% to 99% when the disease is caught before it has spread beyond nearby lymph nodes. Being diagnosed late in the rural South versus the rural Midwest is, in many cases, the difference between a treatable disease and a terminal one.

The study's lead author, Omolade Sogade, a surgery resident at Washington University, described the geographic disparities as "quite striking" and noted that a woman's place of residence was one important factor shaping her risk of late diagnosis.

Race and insurance compound geography

Geography tells only part of the story. Race and insurance status layered additional risk on top of regional differences.

Compared with White women, Black women were 58% more likely to be diagnosed with Stage 3 breast cancer and 28% more likely to reach Stage 4 before detection. Hispanic women were 52% more likely to present at Stage 3. These disparities persisted after adjusting for other factors, pointing to systemic barriers that extend beyond geography alone.

Insurance status was the single most powerful predictor. Uninsured women were roughly twice as likely to be diagnosed at Stage 3 and nearly four times as likely to be diagnosed at Stage 4, compared with women carrying private insurance. Even Medicaid, which provides some level of coverage, was associated with nearly triple the risk of Stage 4 diagnosis relative to private insurance.

The pattern is consistent with a well-documented cycle: without insurance, women are less likely to receive routine mammograms, less likely to follow up on suspicious findings, and more likely to present with symptoms only after the cancer has advanced. In rural areas, where the nearest screening facility may be hours away and transportation options are limited, these barriers multiply.

A workforce problem beneath the numbers

Several structural factors help explain why rural breast cancer outcomes lag. Approximately 60% of rural counties lack an active general surgeon. Only about 3% of oncologists primarily practice in rural communities. Long travel distances to screening facilities, combined with workforce shortages and lower health literacy, create compounding delays.

The study found that the type of treatment facility did not independently affect stage at diagnosis after adjusting for other variables. In other words, the problem is not that rural hospitals are providing worse care once a patient arrives. The problem is getting patients there in time.

Senior author Julie Margenthaler, a professor of surgery at Washington University and director of breast surgical services, emphasized that solutions must be tailored to specific regions. A program that works in Iowa will not necessarily address the barriers facing women in rural Mississippi. Surgical training programs like the ACS Rural Surgery Program fellowship are designed to attract surgeons to underserved areas, but workforce development alone will not close the gap without simultaneous investment in screening access, transportation, and insurance coverage.

What the data cannot show

The study draws on hospital-level data from the National Cancer Database, which captures cases from accredited cancer programs. It may not include patients who were never diagnosed or who received care outside the accredited system. Individual-level factors, such as health beliefs, family obligations that delay medical visits, or distrust of the healthcare system, are not captured in this dataset.

The 17-year time span also means the data includes periods before the Affordable Care Act expanded Medicaid in many states and periods after. Whether Medicaid expansion in some southern states has begun to narrow these disparities is a question the current analysis cannot answer but future research should address.

Population-level analyses with patient-specific data could reveal barriers that hospital records miss, including how far women travel for screening, how long they wait between a suspicious mammogram and a biopsy, and whether cultural or language factors influence when they seek care.

The findings were presented at the 137th Annual Meeting of the Southern Surgical Association and are now published online. They add specificity to a problem that is often discussed in broad terms. Rural breast cancer outcomes are not uniformly bad. They are bad in particular places, for particular populations, for identifiable reasons. That specificity is what makes the problem addressable.